Latest Non-Redemption Agreements: Deep Medicine Acquisition Corp. and AP Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) Adds Non-Redemption Agreement
On July 11, 2023, Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) and Bright Vision Sponsor LLC entered into certain non-redemption agreements with certain unaffiliated third parties in exchange for such third parties agreeing not to redeem certain shares of Class A common stock in connection with the special meeting to consider and approve an extension from July 29, 2023 to January 29, 2024.
In exchange for the foregoing commitments not to redeem such shares, the sponsor has agreed to transfer to such third parties certain shares of Class A Common Stock held by the sponsor immediately following consummation of an initial business combination if they continue to hold such shares through the meeting. Such founder shares had been issued to the sponsor upon conversion of the Class B common stock.
In addition, the company has agreed that, to mitigate the current uncertainty surrounding the implementation of the Inflation Reduction Act of 2022, funds held in the trust account will not be used to pay for any excise tax liabilities with respect to any future redemptions prior to or in connection with the extension, an initial business combination, or liquidation.
Deep Medicine and the sponsor have entered into Non-Redemption Agreements with two unaffiliated third parties with respect to a maximum aggregate of 22,606 Non-Redeemed Shares, and the sponsor has agreed to transfer a maximum aggregate of 8,138 Founder Shares pursuant to the Non-Redemption Agreements.
READAP Acquisition Corp. (APCA) Adds Non-Redemption Agreement
On July 7, 2023, AP Acquisition Corp (NYSE:APCA) entered into a deed of non-redemption with TOKYO CENTURY CORPORATION in connection with the extraordinary general meeting of the SPAC’s shareholders to consider and approve the business combination.
Pursuant to the deed, the Non-Redeeming Shareholder agreed that it will not elect to redeem, tender or submit for redemption, or otherwise exercise its SPAC Shareholder Redemption Right with respect to, 500,000 Class A ordinary shares of SPAC.
In addition, the deed provides that the Non-Redeeming Shareholder shall not sell, transfer, tender, grant, pledge, assign or otherwise dispose of encumber, hedge or utilize a derivative to transfer the economic interest in or enter into any contracts, option or other arrangement with respect to the transfer of, any shares to any person other than pursuant to the business combination at closing.
The deed is expected to increase the amount of funds that will remain in the trust following the meeting.
READ
Mobiv Acquisition Corp. (NASDAQ:MOBV) announced this afternoon that it has closed its combination with EV motorcycle-maker SRIVARU. Shareholders originally approved the deal at a special meeting held back on September 28, but at that time, the parties expected the transaction to take just a week to close. Redemptions whittled Mobiv’s IPO share pool of 10,005,000 down...
Achari Ventures I (NASDAQ:AVHI) has entered into a definitive agreement to combine with medtech firm Vaso Corporation at an equity value of $176 million, or 19.5x its 2022 adjusted EBITDA. Wuxi, China-based Vaso provides IT services and sales support to medical device manufacturers. The combined company is expected to trade on the Nasdaq under the...
EF Hutton Acquisition Corp. I (NASDAQ:EFHT) announced this morning that its shareholders have approved its business combination with E.C.D. Auto Design. At the meeting, there were 5,089,203 shares of common stock, representing approximately 76.82% of the issued and outstanding shares of common stock, present. In connection with the meeting, the company’s stockholders holding 3,470,945 shares,...
Legato Merger Corp. III (NYSE:LEGT) filed for a $175 million IPO yesterday afternoon, becoming the fourth SPAC to file this week. While the other three SPACs that filed their S-1s earlier this week intend to pursue targets in the financial services and biotech industries, Legato III, similar to the earlier Legato SPACs, will focus on...
At the SPAC of Dawn This week ends with an unusually busy earnings calendar as 172 US-listed companies report quarterly figures today. Among them is Exela Technologies (NASDSAQ:XELA), which completed a combination with Quinpario 2 in 2017. The billing software company has gone on to do another SPAC deal on November 29, this time spinning...